Gentex vs Visteon
GNTX and VC side by side, both in motor vehicles and motor vehicle equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GNTX and VC compare
Gentex is the larger company, worth 2.1 times as much as Visteon ($4.0B against $1.9B).
On earnings, Gentex is cheaper: it trades at 10.0× trailing earnings, against 13.4× for Visteon.
Gentex grew revenue faster over the last twelve months (10.1% versus 1.9% for Visteon).
Gentex keeps more of each dollar of sales as profit, with a net margin of 15.5% compared with 4.1% at Visteon.
Both pay dividends: Gentex yields 2.5% and Visteon 1.8%.
Gentex scores higher on the StockData Score (20 against 16 for Visteon), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GNTX | VC |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $1.9B |
| Share price | $18.97 | $77.91 |
| Change, 1 year | −18.5% | −26.5% |
| Change, 5 years | −46.7% | −31.2% |
| Beta (5Y) | 0.32 | 0.82 |
| Employees | 6,398 | 11K |
| StockData Score | ||
| Total score | 20 (better) | 16 |
| Valuation score | 5 | 6 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 5 (better) | 2 |
| Health score | 3 | 5 (better) |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 10.0× (better) | 13.4× |
| P/S | 1.5× | 0.5× (better) |
| P/B | – | 1.4× |
| EV/EBITDA | 6.2× | 5.7× (better) |
| P/FCF | 8.0× | – |
| PEG | 1.17 | 0.72 (better) |
| FCF yield | 12.4% | – |
| Fair value | $32.14 | $114.15 |
| Margin of safety | 41.0% (better) | 31.7% |
| Growth | ||
| Revenue growth (TTM) | 10.1% (better) | 1.9% |
| Revenue growth, 5Y average | 8.5% (better) | 8.1% |
| Net income growth (TTM) | 1.5% (better) | −36.9% |
| EPS growth (TTM) | 6.8% (better) | −36.2% |
| EPS growth, 5Y average | 4.3% | – |
| Profitability | ||
| Gross margin | 35.0% (better) | 10.4% |
| Operating margin | 19.3% | – |
| Net margin | 15.5% (better) | 4.1% |
| FCF margin | 18.9% | – |
| Return on equity | 16.8% (better) | 10.8% |
| Return on invested capital | 18.5% | – |
| Financial health | ||
| Debt / equity | – | 0.23 |
| Net debt / EBITDA | −0.39 | −0.41 |
| Current ratio | 3.04 (better) | 1.61 |
| Altman Z-score | 7.70 (better) | 3.15 |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 2.5% (better) | 1.8% |
| Payout ratio | 25.6% | 22.6% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 6.1% | 14.9% (better) |
| Shareholder yield | 8.6% | 16.7% (better) |
| Ownership | ||
| Held by institutions | 99.4% | 129% |
| Held by insiders | 0.37% | 2.0% |
| Insider net buying, 12 months | −$2.8M (better) | −$11.8M |
| Short interest, % of float | 9.0% | 16.8% |
Go deeper
- GNTX stock overview
- GNTX income statement
- GNTX valuation and score
- VC stock overview
- VC income statement
- VC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.